Compare ETRA & NWAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ETRA | NWAX |
|---|---|---|
| Founded | 2018 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 593.1M | 499.5M |
| IPO Year | 2026 | 2025 |
| Metric | ETRA | NWAX |
|---|---|---|
| Price | $8.14 | $10.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $33.20 | N/A |
| AVG Volume (30 Days) | ★ 315.5K | 199.4K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.87 | $9.68 |
| 52 Week High | $15.14 | $10.34 |
| Indicator | ETRA | NWAX |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 41.04 |
| Support Level | $7.58 | $10.02 |
| Resistance Level | $9.68 | $10.09 |
| Average True Range (ATR) | 1.15 | 0.02 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 50.55 | 16.67 |
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.
New America Acquisition I Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to throughout this prospectus as its initial Business Combination.